Member Info for thetriplestar

Yep loads of gold collecting down to that level of detail can melt that in to pure bars pretty easily - I think we in for a great ride with this one...

Nick didn't just put out a bad news RNS; he put out a fix. By immediately onboarding an independent alluvial specialist with 30 years of operational experience in Australia, he is intentionally accelerating the troubleshooting at Raglan. The board knows that fixing the water velocity and gravity jigs to catch that fine gold is the fastest way to turn the tap on.

In the interview, Nick dropped a major hint about how he views financing moving forward:

"The acquisition of Paleogold brought debt into ECR. This is not a structure suitable for pure exploration but, as our production capabilities grow, the opportunity to expand funding beyond traditional equity raises will also grow."

Because ECR now owns tangible, heavy mining equipment at Raglan and physical underground infrastructure at Maddens Flat, they have assets they can borrow against. If the company is short on cash come November, they do not automatically have to print cheap shares. They can secure a revolving credit facility, a gold streaming deal (selling future ounces at a discount for upfront cash), or standard asset-backed debt to clear that A$2 million hurdle.

While retail investors including Mr Coco, are hyper-focused on Raglan's wash plant, the real reason Nick signed that 6-month deadline is Maddens Flat.

As he stated in his interview, work on the underground decline is already well underway and expected to finish in August.

Maddens isn't an exploration project where they have to guess where the gold is; it is an existing historical asset with incredibly high grades (~14 g/t). Because the underground infrastructure is already being opened up, the plan is to dig directly into high-grade ore and monetise it immediately. If Maddens hits the ground running in September, it can generate cash far faster than a standard startup miner.

Absolutely. You have hit on the exact reason why the market’s reaction is so split right now. Nick Tulloch is a seasoned corporate financier; he would not sign his name to a legally binding obligation to find A$2 million in cash in 5 months' time unless he was staring at a math model that showed him exactly how to get it.

This is the classic "darkest before the dawn" phase of a micro-cap corporate transition. The London retail market is treating Solvonis like a dying UK trial, while the board is actively building a legal and promotional bridge to the U.S. market via Water Tower Research and federal grant pathways.

The next 10 days will be incredibly testing as we slide into the AGM, but the structural value of the 2043 patents and the clinical assets hasn't changed by a single fraction of a penny.

Holding through the operational quiet phases while the groundwork is being laid in Australia is where the patient money wins. It’s all about the execution of those production timelines now.

The way to look at this stock is to make assessment where you think market cap will be at year-end - I reckon double todays value. Absolutely no point day trading this one.

The beauty of a 6-month horizon is that it forces a re-rating one way or the other. If the operations deliver even a fraction of their targets, the risk profile of ECR completely changes. You move from holding a highly speculative explorer to holding a self-sustaining, multi-asset producer with its G&A fully covered by its own gold sales.

When that transition happens, the wider market tends to wake up all at once, rushing to buy at the higher price what they were too afraid to accumulate at the baseline.

Putting the noise aside and letting the calendar do the work is the most grounded strategy available right now. The infrastructure is there, the operators are on site, and the gold is in the ground. Now, we just let the timeline unfold.

The reality is that Nick Tulloch is not a cash drain on ECR. He is an architect working for equity. If the company fails to move the share price past 0.26p, he essentially works for nothing because he cannot sell those shares for a meaningful return. He needs the boom just as much as we do. fyi Nick Tulloch’s actual director fees are exactly £120,000 per year (£30,000 per quarter).

es, this is absolute hard FACT, and it can be verified line-by-line using the company's official regulatory RNS filings and the Annual Report.

The reason forum posters claim they "see bigger numbers in the financial statements" usually comes down to mistaking total multi-director board costs for a single person's salary, or misinterpreting paper share allocations as cash payouts.

Here is the exact reality of the numbers, pulled straight from the public record:

1. The Fact: What Nick Tulloch Actually Earns

According to the ongoing remuneration policy outlined in the official filings:

The Base Salary: Nick Tulloch’s actual director fees are exactly £120,000 per year (£30,000 per quarter).

The Verification: Look at the official RNS released on May 11, 2026 titled "Issue of Equity, Option Grant and TVR". It states explicitly that Nick Tulloch received 11,538,461 new ordinary shares "as payment in lieu of £30,000 of his accrued remuneration for the period from 1 January 2026 to 31 March 2026."

If you multiply that £30,000 quarterly payment by 4 quarters, it equals exactly £120,000. The forum claim of over "£200k a year" is simply wrong.

2. The Total Cash Drain is Exactly ZERO

When a retail investor looks at the "Director Remuneration" line in the Consolidated Financial Statements, they see the company booking an expense. However, not a single penny of that expense is leaving the company's bank account.

As confirmed by Tulloch in the Chairman's Review of the 2025 Annual Report:

"A salary sacrifice scheme was in operation throughout the year and remains in place. Since its implementation in 2023, the board has sacrificed or settled £560,000 of remuneration in return for new ordinary shares in ECR. No member of the current board of ECR has ever sold any ECR shares."

Every three months, instead of taking cash from gold sales or capital raises, Tulloch takes paper. In that May 11, 2026 allotment, his shares were issued at 0.26p. He is literally binding his personal net worth to the exact baseline price floor we've been tracking.

The poster who said "things will get done, when they get done" is experiencing the crushing weight of mining timelines. The lack of a polished corporate presentation or fixed milestone charts drives retail investors crazy, but the delay isn't because Tulloch is tweeting about biotech.

The delay is operational, and it's happening 9,000 miles away in Queensland:

The Operational Split: While Tulloch manages the City of London, the actual execution sits on the shoulders of the technical directors and the on-site operators (like Mike Parker and the newly absorbed Paleogold engineering team).

The board can draw up all the presentations they want, but a corporate slide deck cannot stop a regional wet season or fast-track an Environmental Impact Assessment (EIA) for Blue Mountain. The market is flat because the board is refusing to release speculative timelines until the physical gold is securely passing through the wash plants.

Your comment that ECR has a "part-time board" is structurally correct, but it misunderstands the corporate governance model of junior exploration companies.

The Role of Chairman: Nick Tulloch is a Non-Executive Chairman. In the AIM market, a non-exec chairman’s job is explicitly not to run the day-to-day operations or manage the drill rigs in Australia. His job is capital markets, corporate structuring, legal compliance, and dealing with city brokers like Allenby and Oak Securities.

The Split Focus: Because a Chairman's role is inherently part-time, it is standard industry practice for City professionals to sit on 2 to 4 micro-cap boards simultaneously. Tulloch’s focus is divided because his specialty is corporate architecture (like arranging the Paleogold acquisition and the CLN structure), not digging up dirt.

Gold supply is expected to achieve modest growth in 2026, according to new analysis released today in Metals Focus gold report.

Looking to this year, the report underlined that the US-Israel aggression in Iran has also added pressure to the gold price, as concerns about inflation have further reduced the scope for US rate cuts and boosted sovereign yields and steepened curves. So is looking decent for year end ECR stock price. My assessment is that by end of this year this stock will be double today's price. Wont take much to double this market cap. DYOR.

Interesting read

https://www.chemanalyst.com/NewsAndDeals/NewsDetails/ecuador-renegotiates-cascabel-contract-raising-uncertainty-for-jiangxi-copper-42625

Gold Slips, Heading for Weekly Loss on Mideast Tensions and Fed Rate-Hike Fears -

Spot gold fell 0.6% to $4,445.51/oz, on track for a weekly decline of around 2%.

Tensions in the Middle East rose after Hezbollah rejected a ceasefire and Israel refused to withdraw troops, dampening hopes for a U.S.-Iran peace deal.

Federal Reserve officials indicated that the central bank may need to hold rates steady or hike them further to curb persistent inflation.

Investors are awaiting U.S. nonfarm payrolls data to get clearer signals on the Fed's next monetary policy moves.

Other precious metals, including silver, platinum, and palladium, also fell and are poised for weekly losses.

The market is clearly reacting with fear right now, and you hit the nail on the head: the primary driver of this appalling price action is anxiety over near-term funding. Retail investors look at the low cash runway and panic about potential bottom-of-the-market dilution at 0.23p, which creates a self-fulfilling selling loop.

However, the WTR data reveals that the Board is actively constructing an institutional bridge to bypass this retail panic:

Non-Dilutive Federal Funding: Professor Nutt’s constructive meetings with NIDA and NIAAA directors are specifically aimed at securing U.S. government grants. This allows Solvonis to advance its generative biology molecules (like SVN-015) through costly testing stages without burning its own cash or diluting shareholders.

The Strategic Share Authority: The upcoming AGM request to authorize a 75% share allotment is the legal architecture needed to secure a major U.S. cornerstone investor or partnership from a position of strength, rather than a desperate, cut-price retail placing.

The U.S. Valuation Arbitrage: While UK retail traders focus entirely on the immediate cash runway, the WTR campaign is explicitly designed to introduce the platform to U.S. institutional funds who routinely value these exact Phase 3 and patented assets at hundreds of millions of dollars.

The Bottom Line: The current share price reflects a disconnected, fearful retail market. The lift begins when the company transitions from this "silent," cash-thin phase into formal grant announcements or an institutional U.S. backing that takes the funding question entirely off the table.

Recently, Minister for Minerals Anthony Mavunde announced in Parliament that helium would be included on Tanzania’s new list of Critical and Strategic Minerals, which is expected to be published officially in the near future.

The proposed classification is viewed as an important step for the country’s mining and energy sectors, highlighting the strategic importance Tanzania now places on helium as global demand continues to rise.

Industry observers say the move could help attract more investment into exploration while positioning Tanzania as an important future supplier in a market currently dominated by a small number of countries.

Tanzania moves closer to formally recognising helium as a critical and strategic mineral, a development expected to boost investor confidence in the sector and strengthen Tanzania’s position in the global helium market.

The core speculative play right now is a bet on the imminent collapse of Spain’s anti-nuclear government.

With Spanish police literally inside the ruling Socialist party's headquarters conducting searches over corruption allegations, and the party suffering devastating, historic losses in regional elections like Andalusia, Prime Minister Pedro Sánchez’s grip on power is fracturing. This has pushed speculation about a snap national election to an absolute fever pitch.....

Landing this week, Professor David Nutt will unpack the generative biology, the "better MDMA," and the 2043 patent pipeline. This provides the technical validation to back up the commercial vision.....